Get startedLog in
    Picture of Hyloris Pharmaceuticals SA logo

    HYL — Hyloris Pharmaceuticals SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapNeutral
    All News

    Brief: Hyloris Pharmaceuticals Sees Sales Growth In 2024

    Picture of Hyloris Pharmaceuticals SA logoHyloris Pharmaceuticals SA
    14/03/2024 06:28
    March 14 (Reuters) - Hyloris Pharmaceuticals SA
 HYL.BR :
    * PROMISING NEW PRODUCT CANDIDATES DRIVING INNOVATION,
TARGETING A
PORTFOLIO OF 30 ASSETS BY 2025
    * STRONGER GROWTH EXPECTED IN 2024 OF BOTH SALES AND GROSS
MARGIN,
MAINLY FUELED BY RECENT LAUNCH IN U.S. OF MAXIGESIC® IV AND
PODOFILOX GEL, GLOBAL ROLL OUT OF MAXIGESIC IV® AND COMMERCIAL
DEALS
    * END-FY EUR 30.2 MILLION IN CASH & CASH EQUIVALENTS, NO
FINANCIAL
DEBT

Source text for Eikon:  ID:nGNE1FdbZm 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Hyloris Pharmaceuticals SA

    See all news